SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Changes in Restructuring Expenses Accrual


Table 2.1: Summary of Restructuring Expenses and Impairment Loss
	Statements of Operations	For the Year Ended December 31,
		2025		2024

		(in thousands)
Severance and related benefit costs	Cost of sales	$	444	$	341
Other related costs (1)	Cost of sales	50		—
Severance and related benefit costs	R&D, SG&A	1,007		929
Total restructuring expenses		1,501		1,270
Impairment of intangible assets (2)	Impairment loss on intangible assets	—		6,373
Total restructuring expenses and impairment loss		$	1,501	$	7,643

(1) Other related costs consist of a non-cash inventory write-off related to the implementation of the 2025 restructuring plan.

(2) The recoverability evaluation of intangible assets in 2024 resulted in an $11.7 million impairment loss, of which $5.3 million was recorded under cost of sales for the discontinued parts of certain solutions, and $6.4 million was recorded under operating expenses as a result of the restructuring plan (see Note 7 - Intangible Assets, Net).

At each reporting date, the Company evaluates its restructuring expense accrual to determine if the liabilities reported are still appropriate. Any changes in the estimated costs of executing the approved restructuring plan are reflected in the Company's consolidated statements of operations.


Table 2.2: Summary of Changes in Restructuring Expenses Accrual
	For the Year Ended December 31,
	2025		2024

	(in thousands)
Severance and related benefit costs (1):
Balance at beginning of year	$	37	$	400
Expenses, excluding non-cash costs	1,451		1,270
Cash payments	(37)		(1,633)
Balance at end of year	$	1,451	$	37

(1) Restructuring expenses accrual is reported as part of "Accrued liabilities" in the Company's consolidated balance sheets, see Note 8 - Other Balance Sheet Components for further details.